Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

1 - 20  of 48716 results

Filter or search again

Sort by:  Latest first

  • Chief pharmacists warned of need for succession planning for procurement roles

    27 NOV 2014

    Succession planning is urgently needed to prepare for the swathe of experienced pharmacists buying medicines for hospitals who will shortly retire, an independent review has warned.

  • Community pharmacists could screen at-risk groups for liver disease

    27 NOV 2014

    According to The Lancet’s commission, community pharmacists could play a key role in helping to improve liver disease services in primary care, say hepatology specialists.

  • Class 2 medicines recall for mitoxantrone

    26 NOV 2014

    The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall (action within 48 hours) for mitoxantrone 2mg/ml concentrate for solution for infusion, manufactured by Hospira UK Limited. This is because of a number of confirmed out of specification test results obtained during stability studies. Pharmacists should quarantine any remaining stock and Hospira will contact customers who may have received the impacted batches to arrange collection via ...

  • Reltebon prolonged release additional strengths

    26 NOV 2014

    Actavis has launched additional strengths of Reltebon (oxycodone hydrochloride) prolonged-release tablets. The product is now available in packs of 15mg x 56, £26.25, 30mg x 56, £52.50 and 60mg x 56, £105.00. These products are in addition to the existing Reltebon Prolonged-Release tablet range.

  • Forceval capsules excipient warning

    26 NOV 2014

    The summary of product characteristics for Forceval capsules, a multivitamin from Alliance, now warns that the product contains soya bean oil and should not be taken by people with soya or peanut allergies.

  • Colestid out of stock

    26 NOV 2014

    Colestid (colestipol hydrochloride) granules, 5g x 30 sachets, is still out of stock from Pfizer. It is expected to be back in stock by early February 2015. Further information on 0845 6088866.

  • Community pharmacy in urgent care

    26 NOV 2014

    As part of NHS England medical director Bruce Keogh’s urgent care review, a document has been published that is designed to provide support to all member organisations of System Resilience Groups across England to make greater use of pharmacies in providing high quality and resilient urgent care locally. It is called ‘Community pharmacy — helping provide better quality ...

  • Anthony Derek John Balon dies

    26 NOV 2014

    On 25 November, Anthony Derek John Balon, aged 79, of 12 Dukes Avenue, Edgware, Middlesex HA8 7RX. Dr Balon registered in 1961, became a fellow in 1992 and left the Society in 2014.

  • Delay to planned management change of NHS smartcard system

    26 NOV 2014

    A planned change to the management of the smartcard system used by pharmacists in England when accessing the electronic prescription service has been delayed.

  • RPS antimicrobial resistance event prompts parliamentary debate

    26 NOV 2014

    Politicians in Scotland are set to debate the next steps to take in order to tackle rising antimicrobial resistance.

  • Ibrutinib launched for treatment of mantle cell lymphoma and chronic lymphocyte leukaemia

    26 NOV 2014

    Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has been launched in the UK for the treatment of mantle cell lymphoma or chronic lymphocyte leukaemia.

  • Otrivine discontinuation

    26 NOV 2014

    Otrivine (Xylometazoline) menthol spray 0.1% 10ml is being discontinued by Novartis. It is expected that stock will be exhausted by the end of December 2014. Further information on 01276 687202.

  • UKMi medicines compliance aid database

    26 NOV 2014

    UK Medicines Information (UKMi) has launched a database that makes recommendations on the suitability of solid dose forms of medicines for transfer from the manufacturers’ original packaging to multi-compartment compliance aids ...

  • Lundbeck’s chief executive resigns after code of ethics breach

    25 NOV 2014

    Ulf Wiinberg has resigned as chief executive of the Danish pharmaceutical company Lundbeck after breaching the company’s code of ethics.

  • Assessing suspected food poisoning cases in the UK weblink

    25 NOV 2014

    With more than 20,000 patients hospitalised in the UK each year due to food poisoning, quick assessment is essential.

  • Medicines regulator amends conflict of interest rules to ensure suitability of experts

    25 NOV 2014

    The European Medicines Agency has amended its policy on handling declarations of interest to ensure pharmaceutical experts are not unduly excluded.

  • Provision of pharmacy services in England has increased, statistics show

    25 NOV 2014

    The number of medicines use reviews and new medicine service interventions has risen steadily in England’s community pharmacies.

  • Cochrane researchers call for better ways of studying medicines adherence

    25 NOV 2014

    Methods to improve patients’ adherence to medicines are generally unproven and there is an urgent need to develop more effective approaches, say researchers.

  • NHS England issues naloxone warning

    25 NOV 2014

    Inappropriate use of naloxone can cause patients severe distress and can be fatal, says NHS England in a Patient Safety Alert.

  • EllaOne to be available without prescription

    25 NOV 2014

    EllaOne (ulipristal acetate), an emergency contraceptive, is to be made available without a prescription from community pharmacies throughout the European Union.

View results  10 per page   20 per page   50 per page  

Filter Your Search